U.S. patent number D468,423 [Application Number D/124,933] was granted by the patent office on 2003-01-07 for container for pharmaceutical substance to be administered nasally.
This patent grant is currently assigned to Glaxo Group Limited. Invention is credited to Bruce Renfrew.
United States Patent |
D468,423 |
Renfrew |
January 7, 2003 |
Container for pharmaceutical substance to be administered
nasally
Claims
The ornamental design for container for pharmaceutical substance to
be administered nasally, as shown and described.
Inventors: |
Renfrew; Bruce (Leicester,
GB) |
Assignee: |
Glaxo Group Limited (Middlesex,
GB)
|
Appl.
No.: |
D/124,933 |
Filed: |
June 14, 2000 |
Foreign Application Priority Data
|
|
|
|
|
Dec 20, 1999 [GB] |
|
|
2088944 |
|
Current U.S.
Class: |
D24/115 |
Current International
Class: |
2402 |
Field of
Search: |
;D24/110,115,119
;D9/520,521,529 ;D28/85 ;220/206,205,212,189,295,302,213,173,184
;128/200.14 |
References Cited
[Referenced By]
U.S. Patent Documents
Foreign Patent Documents
|
|
|
|
|
|
|
813302 |
|
Jun 1991 |
|
JP |
|
831531 |
|
Mar 1992 |
|
JP |
|
869158 |
|
May 1993 |
|
JP |
|
952618 |
|
Jan 1999 |
|
JP |
|
Primary Examiner: Simmons; Ian
Attorney, Agent or Firm: Darby & Darby
Description
FIG. 1 is a perspective view of a container for pharmaceutical
substance to be administered nasally, as viewed from the front,
showing my new design;
FIG. 2 is a perspective view thereof, as shown from the rear;
FIG. 3 is a right side elevational view thereof, the left side
elevational view being a mirror image thereof;
FIG. 4 is a front elevational view thereof;
FIG. 5 is a rear elevational view thereof; and,
FIG. 6 is a top plan view thereof.
* * * * *